Rehmann Capital Advisory Group purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,871 shares of the pharmacy operator’s stock, valued at approximately $ 202,000.
A number of other institutional investors have also bought and sold shares of the business. New World Advisors LLC purchased a new position in Walgreens Boots Alliance during the 3rd quarter worth approximately $ 392,000. MML Investors Services LLC grew its position in Walgreens Boots Alliance by 7.6% during the 3rd quarter. MML Investors Services LLC now owns 29,502 shares of the pharmacy operator’s stock worth $ 1,388,000 after purchasing an additional 2,086 shares in the last quarter. Wellington Management Group LLP grew its position in Walgreens Boots Alliance by 21.3% during the 3rd quarter. Wellington Management Group LLP now owns 6,396 shares of the pharmacy operator’s stock worth $ 301,000 after purchasing an additional 1,121 shares in the last quarter. Verition Fund Management LLC grew its position in Walgreens Boots Alliance by 53.3% during the 3rd quarter. Verition Fund Management LLC now owns 27,748 shares of the pharmacy operator’s stock worth $ 1,306,000 after purchasing an additional 9,650 shares in the last quarter. Finally, United Capital Financial Advisers LLC grew its position in Walgreens Boots Alliance by 21.8% during the 3rd quarter. United Capital Financial Advisers LLC now owns 139,070 shares of the pharmacy operator’s stock worth $ 6,543,000 after purchasing an additional 24,919 shares in the last quarter. Hedge funds and other institutional investors own 57.02% of the company stock.
In other Walgreens Boots Alliance news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the business’s stock in a transaction on Wednesday, May 11th. The shares were sold at an average price of $ 150.00, for a total transaction of $ 900,000,000.00. Following the completion of the transaction, the insider now owns 52,854,867 shares of the company stock, valued at approximately $ 7,928,230,050. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 17.40% of the stock is owned by insiders.
WBA stock opened at $ 39.32 on Monday. The company has a current ratio of 0.74, a quick ratio of 0.35 and a debt-to-equity ratio of 0.36. Walgreens Boots Alliance, Inc. has a 1 year low of $ 39.14 and a 1 year high of $ 55.00. The company has a fifty day simple moving average of $ 43.27 and a 200 day simple moving average of $ 46.97. The firm has a market cap of $ 33.96 billion, a PE ratio of 5.42, a PEG ratio of 1.55 and a beta of 0.55.
Walgreens Boots Alliance (NASDAQ: WBA – Get Rating) last released its quarterly earnings data on Thursday, March 31st. The pharmacy operator reported $ 1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $ 1.39 by $ 0.20. The business had revenue of $ 33.76 billion during the quarter, compared to analyst estimates of $ 33.33 billion. Walgreens Boots Alliance had a net margin of 4.62% and a return on equity of 19.15%. Walgreens Boots Alliance’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $ 1.40 EPS. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 5.06 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, June 10th. Shareholders of record on Friday, May 20th were given a dividend of $ 0.4775 per share. This represents a $ 1.91 dividend on an annualized basis and a yield of 4.86%. The ex-dividend date was Thursday, May 19th. Walgreens Boots Alliance’s dividend payout ratio is 26.34%.
Several equities analysts have weighed in on the stock. Barclays lowered their price objective on shares of Walgreens Boots Alliance from $ 54.00 to $ 50.00 and set an “equal weight” rating on the stock in a research report on Friday, April 1st. Robert W. Baird cut shares of Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and lowered their price target for the stock from $ 70.00 to $ 51.00 in a research report on Friday, April 1st. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $ 50.00 to $ 43.00 and set an “underweight” rating on the stock in a report on Thursday, June 2nd. Cowen lowered their price target on shares of Walgreens Boots Alliance from $ 55.00 to $ 50.00 in a report on Tuesday, April 12th. Finally, Royal Bank of Canada lowered their price target on shares of Walgreens Boots Alliance from $ 52.00 to $ 46.00 and set a “sector perform” rating on the stock in a report on Friday, April 1st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $ 49.77.
About Walgreens Boots Alliance: (Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Recommended Stories:
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get Rating).
Receive News & Ratings for Walgreens Boots Alliance Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s FREE daily email newsletter.
.